INNOBIOVIR is the synergetic alliance between two cutting-edge academic laboratories (LAGEPP, VirPath) and two training centres (IPIL, IUT Lyon 1), aiming to propose cross-competency expertises in the fields of bioproduction, formulation and evaluation of viral antigens and bio-compounds.
Addressed to both public and private innovators in the field of public health, INNOBIOVIR combines competencies all along the value chain of product and process development, with a particular focus on viral production and galenic methods.
INNOBIOVIR deploys its capabilities over more than 500 m2 of technical floors, including BioSafety Level 2 and 3 facilities to support R&D projects, realization of on-demand services and advanced trainings.
Company Details
- Employees
- 2
- Address
- Lyon, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Lyon
- Competitors
- UniVR Studio - Réalité virtuelle pour la formation professionnelle, Clean Cells, GEMELI Platform, ESACT - European Society for the Advancement of Cell Technology, B.I.F.E. Bio Ingeniería en la Fabricación de Elaborados, FERMENTALG, ClinSearch - CAST® - EDClin™, AAADVISORY, Hearten Biotech, Delta Biotech S.A..
Innobiovir Questions
Innobiovir's website is https://innobiovir.univ-lyon1.fr/
Innobiovir's LinkedIn profile is https://fr.linkedin.com/company/innobiovir
Innobiovir has
2 employees.
View email and phone details for 2
employees at Innobiovir.
Innobiovir's industry is
Biotechnology Research
Innobiovir's top competitors are
Univr Studio - Réalité Virtuelle Pour La Formation Professionnelle,
Clean Cells,
Gemeli Platform,
Esact - European Society For The Advancement Of Cell Technology,
B.i.f.e. Bio Ingeniería En La Fabricación De Elaborados,
Fermentalg,
Clinsearch - Cast® - Edclin™,
Aaadvisory,
Hearten Biotech,
Delta Biotech S.a..
Innobiovir's categories are Biotechnology Research
